CTVA.NYSECorteva, INC

10-Q: Corteva Reports Mixed Q3 Results Amidst Restructuring and Market Headwinds

Sentiment:

Quarterly Report


Corteva's third-quarter results show a net loss, impacted by pricing pressures and restructuring charges, despite some volume growth in Crop Protection.

Worse than expectedThe company's net loss and decreased operating EBITDA in Q3 2024 were worse than the same period last year.The company's full-year 2024 operating earnings per share is expected to be down 5% at the mid-point.

Summary

  • Corteva reported a net loss of $524 million for the third quarter of 2024, compared to a net loss of $321 million in the same period last year.
  • Net sales decreased by 10% year-over-year to $2.326 billion, driven by an 8% decrease in price and a 5% unfavorable currency impact, partially offset by a 3% increase in volume.
  • The company's cost of goods sold decreased to $1.565 billion from $1.646 billion year-over-year, due to favorable currency effects, cost and productivity actions, and raw material deflation in Crop Protection.
  • Restructuring and asset-related charges increased to $32 million, primarily related to the Crop Protection Operations Strategy Restructuring Program.
  • Operating EBITDA was a loss of $100 million, down from a profit of $18 million in the same quarter last year, due to price declines, higher Seed commodity costs, and increased R&D spending.
  • For the first nine months of 2024, net sales were $12.930 billion, down 4% year-over-year, with a 2% decrease in volume and a 2% unfavorable currency impact.
  • Operating EBITDA for the first nine months of 2024 was $2.851 billion, down from $2.995 billion in the same period last year.
  • The company returned approximately $1.1 billion to shareholders through share repurchases and dividends during the first nine months of 2024.

Sentiment

Score: 4

Explanation: The document presents a mixed picture with negative results in the short term, but with some positive aspects such as cost management and productivity improvements. The outlook is cautious, and the company is facing significant headwinds.

Positives

  • Crop Protection volume increased due to demand for new products and spinosyns in Latin America and North America.
  • Cost of goods sold decreased due to favorable currency effects, cost and productivity actions, and raw material deflation in Crop Protection.
  • The company returned approximately $1.1 billion to shareholders through share repurchases and dividends during the first nine months of 2024.
  • Seed pricing increased due to the continued execution on the company's price for value strategy as led by North America.

Negatives

  • Net sales decreased by 10% in Q3 2024, driven by price declines and unfavorable currency impacts.
  • Operating EBITDA was a loss of $100 million in Q3 2024, down from a profit of $18 million in Q3 2023.
  • The company reported a net loss of $524 million in Q3 2024, compared to a net loss of $321 million in Q3 2023.
  • Seed volumes declined due to reduced corn planted area in Argentina.
  • Crop Protection pricing declined due to the competitive environment in Latin America.
  • The company's restructuring and asset-related charges increased to $32 million in Q3 2024.

Risks

  • The company faces risks related to regulatory approvals, product development, and market acceptance of its products.
  • Changes in agricultural policies, climate change, and competition could impact the company's performance.
  • The company is exposed to risks related to its global operations, supply chain, and intellectual property.
  • The company faces risks related to environmental litigation and indemnification obligations of legacy EIDP liabilities.
  • The company is exposed to risks related to the volatility in input costs and geopolitical and military conflicts.
  • The company is exposed to risks related to the outcome of the Federal Trade Commission investigation and related lawsuits.

Future Outlook

For full-year 2024, the company expects net sales in the range of $17.0 billion to $17.2 billion, operating EBITDA in the range of $3.35 billion to $3.45 billion, operating earnings per share in the range of $2.50 to $2.60 per share, and free cash flow in the range of $1.5 billion to $2.0 billion.

Management Comments

  • Management believes that these non-GAAP measures best reflect the ongoing performance of the company during the periods presented and provide more relevant and meaningful information to investors.
  • Management believes that Free Cash Flow provides investors with meaningful information regarding the company's ongoing ability to generate cash through core operations.

Industry Context

The report indicates a challenging environment for the agricultural sector, with competitive pricing pressures in Crop Protection and reduced planted areas impacting Seed sales. The company is actively managing costs and productivity while investing in R&D to maintain its competitive position.

Comparison to Industry Standards

  • The report does not provide specific comparisons to industry standards or competitors.
  • However, the challenges faced by Corteva, such as pricing pressures and reduced planted areas, are likely affecting other companies in the agricultural sector.
  • The company's focus on cost management and productivity improvements is a common strategy in the industry to navigate market headwinds.
  • The company's investment in R&D is consistent with the industry's need for innovation to develop new products and technologies.

Legal Proceedings

  • The company is subject to various legal proceedings, including product liability, intellectual property, antitrust, commercial, property damage, personal injury, environmental and regulatory matters.
  • The company is involved in a Federal Trade Commission investigation and related lawsuits alleging unfair methods of competition.
  • The company is involved in personal injury lawsuits related to chlorpyrifos exposure.
  • The company is involved in various legal proceedings relating to the use of PFOA by its former Performance Chemicals segment.
  • The company is involved in various legal proceedings relating to the use of PFAS, including AFFF, by its former Performance Chemicals segment.
  • The company is involved in various legal proceedings relating to the use of GenX by its former Performance Chemicals segment.
  • The company is involved in various legal proceedings relating to the AltEn facility in Nebraska.
  • The company is involved in a lawsuit with the California Department of Toxic Substances Control regarding the Pittsburg plant.

Related Party Transactions

  • EIDP has a related party loan receivable from Corteva, Inc. related to the Master In-House Banking Agreement.
  • EIDP earned interest income from Corteva, Inc. under the Master In-House Banking Agreement.
  • EIDP has payables to Corteva, Inc. related to Corteva's indemnification liabilities to Dow and DuPont per the Separation Agreements.

Stakeholder Impact

  • Shareholders are impacted by the net loss and decreased operating EBITDA, but also benefit from share repurchases and dividends.
  • Employees are impacted by restructuring actions, including potential job losses.
  • Customers may be impacted by changes in product pricing and availability.
  • Suppliers may be impacted by changes in the company's supply chain and purchasing patterns.
  • Creditors are impacted by the company's debt levels and ability to generate cash.

Next Steps

  • The company expects to complete the restructuring actions associated with the Crop Protection Operations Strategy Restructuring Program by the end of 2026.
  • The company expects to continue a meritorious defense of its business practices in the Federal Trade Commission investigation and related lawsuits.
  • The company expects to continue to pursue a resolution of a matter under the terms of the Tax Matters Agreement with DuPont and Dow, with the dispute resolution process expected to be concluded in the first half of 2025.

Key Dates

DateDescription
2017-08-31Merger of equals strategic combination between Historical Dow and Historical DuPont.
2019-04-01Separation of DowDuPont's materials science business into a separate and independent public company (Dow Distribution).
2019-06-01Corteva, Inc. became an independent, publicly traded company (Separation of Corteva).
2021-01-22Chemours, DuPont, Corteva and EIDP entered into a binding memorandum of understanding (MOU) to resolve legal disputes and establish a cost sharing arrangement for PFAS liabilities.
2022-09-13Corteva, Inc. announced that its Board of Directors authorized a $2 billion share repurchase program.
2023-03-01Corteva completed the acquisitions of Stoller Group, Inc. and Quorum Vital Investment, S.L. and its affiliates (Symborg).
2023-11-05Management of the company approved a plan to further optimize its Crop Protection network of manufacturing and external partners (the Crop Protection Operations Strategy Restructuring Program).
2024-02-01The company amended and restated its 364-day revolving credit agreement (the 364-Day Revolving Credit Facility) increasing the facility amount to $1 billion and extending the expiration date to February 2025.
2024-06-01The Revolving Credit Facilities were refinanced for purposes of extending the maturity dates for the five-year and three-year revolving credit facilities to June 2029 and June 2027, respectively.
2024-09-30End of the quarterly period for this report.
2024-10-31Corteva, Inc. had 687,293,000 shares of common stock outstanding.
2024-11-07Date of this report.

Keywords

Corteva, Crop Protection, Seed, Operating EBITDA, Net Sales, Restructuring, Financial Results, Agriculture, Agrochemicals, Germplasm

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.